Angiotensin-converting enzyme-2 (ACE-2), an emerging target for treatment of acute respiratory distress syndromes (ARDS), was identified as a specific receptor for SARS-CoV-2 (Gheblawi et al., 2020) . Here, ACE2 is linked to acute respiratory distress syndrome.